Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

GERN

GERON CORP

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • GERNGeron Corporation
    0Calm

    A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

    Running, no new patientsPhase 3327 patientsMain results: Jun 30, 2028

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 0 purchases

No insider sales or purchases in the last 6 months.

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Quarterly reportQuarterly report (10-Q)Nov 4, 2026
  • Shared quarterly resultsNews report (8-K)Nov 4, 2026
  • Other newsNews report (8-K)Oct 28, 2026
  • Shared quarterly resultsNews report (8-K)Aug 6, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 5, 2026
  • An executive or board member joined or leftNews report (8-K)

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
May 27, 2026